Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe and the United States of America (USA).
The aim of the trial is to evaluate the safety and efficacy of NNC-0156-0000-0009 (nonacog
beta pegol) during surgical procedures in patients with haemophilia B.